NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP
Smith & Nephew PLC SNN
11 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$6.2B
▲ 6.1% vs FY2024
EPS · FY25
$0.72
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
11.8%
Net margin · FY25
10.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 6.2B
Revenue, FY2025 · full 11-year series below
Revenue
Net income
10 cents of every revenue dollar became profit this year.
Per share
USD 0.72
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
11.8%
Return on equity, FY2025
ROE
Operating margin12.9%
Net margin10.1%
Return on assets6.0%
Each USD of equity produced 12 cents of profit this year.
Returned to shareholders
USD 502.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 502.0M
Share of profit80.3%
Consecutive raises—
USD 502.0M in buybacks — 80% of the year's profit went back to shareholders.
Growth
+6.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+5.7%
+6.2%
+2.9%
Net income
+41.0%
+6.9%
+4.3%
EPS, diluted
+41.1%
+6.9%
+4.6%
Returned to shareholders
+47.3%
+104.6%
+23.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 10.5B
total assets, end of FY2025
Total assetsUSD 10.5B
EquityUSD 5.3B
CashUSD 557.0M
Gross debtUSD 3.1B
Net debtUSD 2.6B
Current ratio2.57×
Net debt stands at 48% of equity.
History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue $B
6.2
5.8
5.5
5.2
5.2
4.6
5.1
4.9
4.8
4.7
4.6
Operating income $B
0.8
0.7
0.4
0.5
0.6
0.3
0.8
0.9
0.9
0.8
0.6
EBITDA $B
·
·
0.6
0.7
0.8
0.5
1.0
1.0
1.4
1.2
1.1
Income tax $B
0.2
0.1
0.0
0.0
0.1
−0.2
0.1
0.1
0.1
0.3
0.1
Net income $B
0.6
0.4
0.3
0.2
0.5
0.4
0.6
0.7
0.8
0.8
0.4
EPS, diluted $
0.72
0.47
0.30
0.26
0.60
0.51
0.60
75.70
0.88
0.88
0.46
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
ROE %
11.8
7.9
5.0
4.1
9.7
8.6
12.0
13.9
17.8
19.8
·
Shares out B
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
43 of 43
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed